| JOURNAL OF CARDIAC FAILURE | 卷:23 |
| Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay | |
| Article | |
| Li, Lin1  Jesdale, Bill M.1  Hume, Anne2  Gambassi, Giovanni3  Goldberg, Robert J.1  Lapane, Kate L.1  | |
| [1] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA | |
| [2] Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA | |
| [3] Univ Cattolica Sacro Cuore, Dept Med Sci, Div Internal Med & Angiol, Rome, Italy | |
| 关键词: Heart failure with reduced ejection fraction; angiotensin-converting enzyme inhibitors; beta-blockers; skilled nursing facility; | |
| DOI : 10.1016/j.cardfail.2017.09.007 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Background: Little is known about guideline-directed pharmacotherapy use in patients with heart failure and reduced ejection fraction (HFrEF) discharged to skilled nursing facilities (SNFs). This study aimed to describe the use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARBs) and evidence-based beta-blockers (EBBBs) among older patients with HFrEF within 90 days after the SNF admission and to identify factors associated with receipt of these medications. Methods and Results: With the use of Minimum Data Set 3.0 cross-linked with Medicare data (2011-2012), we studied 35,792 Americans aged years with HFrEF admitted to 10,333 SNFs. The median age was 82 years, 59% were women, 81% had at least moderate physical limitations, and 39% had moderate/severe cognitive impairment. Fifty-six percent received an ACEI/ARB and 53% an EBBB; one-fourth received neither. In a multivariable log-binomial model, advanced age, severe physical limitations, and greater number of comorbid conditions not associated with heart failure were inversely associated with ACEI/ARB and EBBB receipt. Conclusions: Use of standard pharmacotherapy among patients with HFrEF after an SNF stay is higher than previously reported. In the absence of evidence demonstrating the effectiveness of ACEIs/ARBs and EBBBs in this population, whether or not improvements in prescribing are warranted remains unknown.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_cardfail_2017_09_007.pdf | 823KB |
PDF